ACOG Menu

Anal Cancer Screening

A MicroRound presented by Christine E. Conageski, MD, MSc, FACOG


About This Presentation

In this presentation, we will …

  • Understand the etiology and epidemiology of anal and perianal cancers
  • Apply lessons learned from cervical cancer prevention to anal cancer prevention
  • Identify available screening methodologies and guidelines
  • Describe the limitations of anal cancer screening, which impact practice patterns and screening availability

Presenter

Christine E. Conageski, MD, MSc, FACOG
Associate Professor, Department of Obstetrics and Gynecology
University of Colorado School of Medicine

Financial Disclosures

  • Pfizer, Inc (relationship ended): Site principal investigator for vaccination trial; funds accepted on Dr. Conageski’s behalf by the University of Colorado for their research team
  • Teal Health, Inc: Site principal investigator for vaccination trial; funds accepted on Dr. Conageski’s behalf by the University of Colorado for their research team

Learn more about the MicroRounds project.